Biosensors & POCT– category –
-
Trinity Biotech and Latch Medical Forge Alliance for AI-Powered Precision Intradermal Drug Delivery in Metabolic Disorders
GlobeNewswire (via Trinity Biotech plc) Ireland Overview Trinity Biotech has announced a strategic partnership with Latch Medical, integrating Trinity's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intraderm... -
Premier Food Safety Conference 2026 Highlights Advanced Biosensors & Portable On-Site Testing for Real-Time Contaminant Detection, Ushering in New Era of Food Safety
Food Science Conferences International Overview The Premier Food Safety Conference 2026 emphasized rapid detection methods as a key topic for food safety, focusing on advanced biosensors, molecular technologies, immunoassays, and portabl... -
Chitosan Hydrogel and Carboxylated Carbon Nanotubes Integrate to Create Highly Stable, Sensitive Red Blood Cell Biosensors for Organophosphate Pesticide Detection
Mirage News International Overview Researchers have developed a novel bio-based strategy using chitosan hydrogel to significantly enhance the stability and selectivity of red blood cell membranes in biosensors. By integrating carboxylate... -
Roche Unveils AXELIOS 1 Next-Gen Sequencing Platform and cobas® Mass Spec at ADLM 2026, Addressing Lab Workforce & Workflow Challenges
PR Newswire (via Roche) Switzerland Overview Roche showcased advanced integrated diagnostic solutions at ADLM 2026, featuring the new AXELIOS 1 next-generation sequencing platform and cobas® Mass Spec solution. These innovations aim to e... -
UT Southwestern Develops Novel Biosensor to Track α-Ketoglutarate, Unraveling Mechanisms of Severe Childhood Brain Disorder and Suggesting Early Intervention
UT Southwestern Medical Center USA Overview Researchers at UT Southwestern's Children's Medical Center Research Institute have developed a novel biosensor capable of tracking alpha-ketoglutarate (αKG), a critical metabolite. Published in... -
Roche Reports 6% H1 2026 Sales Growth, Secures CE Marks for New Alzheimer’s and TB Blood Tests, Acquires AI Pathology Firm PathAI
Roche (Official Press Release), Fierce Biotech Switzerland Overview Roche reported robust 6% sales growth in H1 2026 at constant exchange rates, with diagnostics contributing 3% despite healthcare price reforms in China. Key advancements... -
Dexcom Selected as First Participant in FDA’s TEMPO Pilot Program to Advance AI-Powered Glucose Health for Early Prediabetes & T2D Intervention
Business Wire (via Dexcom Investor Relations) USA Overview Dexcom has been selected as the inaugural participant in the FDA's TEMPO (Technology-Enabled Meaningful Patient Outcomes) digital health devices pilot program, aiming to accelera... -
Lidsen Paper Details Advances in Gold Nanoparticles-Based Colorimetric Assays Using Aptamers for Rapid Food Detection
Lidsen International Overview Research published in Lidsen discusses advancements in gold nanoparticles-based colorimetric assays using aptamers for rapid food detection. It emphasizes how aptamers, as biorecognition elements, combined w... -
bioRxiv: SMART-NeuroDx Achieves Reagent-Free, ML-Driven 4-Analyte Dementia Screening with LoD of 0.087 pg/mL
bioRxiv USA Overview A preprint published on bioRxiv on July 23, 2026, describes SMART-NeuroDx, a reagent-free multianalyte biosensor platform with machine-learning (ML) readout. Aimed at point-of-care dementia screening, this platform a... -
MDPI Review: Electrochemical Aptamer Sensors Revolutionize In Vivo Pharmacokinetic Monitoring of Anthracycline Chemotherapeutics
MDPI (Biosensors) Switzerland Overview A review in MDPI's Biosensors discusses the mechanisms, stability, and clinical translation landscape of electrochemical aptamer-based (EAB) sensors for in vivo pharmacokinetic monitoring of anthrac...
